Polyunsaturated fatty acids: host-derived antimicrobials against glycolytic Staphylococcus aureus

ABSTRACT Metabolic flexibility allows Staphylococcus aureus to survive killing by antibiotics and antimicrobial immune molecules while infecting every niche of the mammalian host. Whether S. aureus is using glycolysis, aerobic respiration, or anaerobic respiration to generate energy, these cellular processes must be accurately attuned to the infected host tissue. Shifting from respiration to glycolysis lowers metabolic throughput, allowing the transition to a persistent S. aureus infection and avoiding killing by most antimicrobial molecules, which typically target rapidly dividing cells. Previously, we reported that arachidonic acid (AA), an abundant host polyunsaturated fatty acid (PUFA), kills S. aureus through a lipid peroxidation mechanism. Here, we report that the extent of PUFA killing of S. aureus can be predicted by the autoxidation rate constant, extending our previous AA findings to include all PUFAs. Contrasting many other antimicrobial molecules, AA kills glycolytic S. aureus more effectively than respiring S. aureus . Elevating cellular ATP levels protects S. aureus from PUFA killing, indicating that glycolytic S. aureus strains cannot sufficiently energize the ATP-dependent processes that allow S. aureus to survive PUFA toxicity. This report defines cellular metabolism as a key determinant in S. aureus PUFA resistance and demonstrates that PUFAs are effective antimicrobials against glycolytic S. aureus , including persister cells and small colony variants. Furthermore, identifying and validating the ATP-dependent processes that protect S. aureus from PUFA killing will define pathways that can be targeted to accentuate killing by the host immune system, leading to the clearance of persistent S. aureus infections. IMPORTANCE Staphylococcus aureus causes significant human morbidity and mortality. The metabolic diversity of this pathogen makes eradication challenging, leading to persistent infections in many patient populations. Polyunsaturated fatty acids (PUFAs) are host-derived antimicrobial molecules that are abundant at the host-pathogen interface. Here, we define the mechanism of killing by PUFAs in metabolically limited S. aureus strains. These strains are difficult to eradicate because most therapies target rapidly dividing cells. We demonstrate that PUFAs kill slow-growing S. aureus through a lipid peroxidation mechanism better than their normal growth counterparts. Restoring ATP levels in these strains protects against PUFA killing, demonstrating that the PUFA survival response is not fully energized in the low metabolic state.

Authors

Institutions

Publication Details

Journal
Journal of Bacteriology
Published
2026-09-17
DOI
https://doi.org/10.1128/jb.00249-26
Primary Topic
Antimicrobial Resistance in Staphylococcus
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Polyunsaturated fatty acids: host-derived antimicrobials against glycolytic Staphylococcus aureus

William N. Beavers, Alex R. Stackhouse, Asif Iqbal, Β. Blank et al.
Journal of Bacteriology
Antimicrobial Resistance in Staphylococcus
article

Polyunsaturated fatty acids: host-derived antimicrobials against glycolytic Staphylococcus aureus

William N. Beavers, Alex R. Stackhouse, Asif Iqbal, Β. Blank, Sara P. Bucher, Wyatt W. Wittliff, Kirsten E. Rico, Michelle Y. MacIntyre, Brooke M. LeBreton, D. Grace Ross
article en

Abstract

ABSTRACT Metabolic flexibility allows Staphylococcus aureus to survive killing by antibiotics and antimicrobial immune molecules while infecting every niche of the mammalian host. Whether S. aureus is using glycolysis, aerobic respiration, or anaerobic respiration to generate energy, these cellular processes must be accurately attuned to the infected host tissue. Shifting from respiration to glycolysis lowers metabolic throughput, allowing the transition to a persistent S. aureus infection and avoiding killing by most antimicrobial molecules, which typically target rapidly dividing cells. Previously, we reported that arachidonic acid (AA), an abundant host polyunsaturated fatty acid (PUFA), kills S. aureus through a lipid peroxidation mechanism. Here, we report that the extent of PUFA killing of S. aureus can be predicted by the autoxidation rate constant, extending our previous AA findings to include all PUFAs. Contrasting many other antimicrobial molecules, AA kills glycolytic S. aureus more effectively than respiring S. aureus . Elevating cellular ATP levels protects S. aureus from PUFA killing, indicating that glycolytic S. aureus strains cannot sufficiently energize the ATP-dependent processes that allow S. aureus to survive PUFA toxicity. This report defines cellular metabolism as a key determinant in S. aureus PUFA resistance and demonstrates that PUFAs are effective antimicrobials against glycolytic S. aureus , including persister cells and small colony variants. Furthermore, identifying and validating the ATP-dependent processes that protect S. aureus from PUFA killing will define pathways that can be targeted to accentuate killing by the host immune system, leading to the clearance of persistent S. aureus infections. IMPORTANCE Staphylococcus aureus causes significant human morbidity and mortality. The metabolic diversity of this pathogen makes eradication challenging, leading to persistent infections in many patient populations. Polyunsaturated fatty acids (PUFAs) are host-derived antimicrobial molecules that are abundant at the host-pathogen interface. Here, we define the mechanism of killing by PUFAs in metabolically limited S. aureus strains. These strains are difficult to eradicate because most therapies target rapidly dividing cells. We demonstrate that PUFAs kill slow-growing S. aureus through a lipid peroxidation mechanism better than their normal growth counterparts. Restoring ATP levels in these strains protects against PUFA killing, demonstrating that the PUFA survival response is not fully energized in the low metabolic state.

Journal of Bacteriology
Louisiana State University (US), Louisiana State University Agricultural Center (US)
NIH Office of the Director, National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 11%
Antimicrobial Resistance in Staphylococcus
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.